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This study demonstrates the presence of positive and
negative regulatory elements within a 2336-base pair-
long region of the rat choline acetyltransferase (ChAT)
gene promoter that cooperate to direct cell type-specific
expression in cholinergic cells. A 21-base pair-long neu-
ron-restrictive silencer element (NRSE) was identified
in the proximal part of this region. This element was
recognized by the neuron-restrictive silencer factor
(NRSF), previously shown to regulate expression of
other neuron-specific genes. The ChAT NRSE was inac-
tive in both cholinergic and non-cholinergic neuronal
cells, but repressed expression from a heterologous pro-
moter in non-neuronal cells. Specific deletion of this
element allowed ChAT gene promoter activity in non-
neuronal cells, and overexpression of NRSF repressed
ChAT gene promoter activity in cholinergic cells. The
distal part of the ChAT gene promoter showed cholin-
ergic-specific enhancing activity, which stimulated pro-
moter activity in cholinergic cells, but was inactive in
non-cholinergic neuronal and non-neuronal cells. This
enhancer region suppressed the activity of the ChAT
NRSE in cholinergic cells, even after NRSF overexpres-
sion. Thus, at least two kinds of regulatory elements
cooperate to direct ChAT gene expression to cholinergic
neurons, namely a neuron-restrictive silencer element
and a cholinergic-specific enhancer.
A fully developed nervous system is characterized by a com-
plex organization of interconnected neurons, each expressing a
specific complement of neurotransmitters and neuromodula-
tors. The elucidation of the molecular mechanisms that govern
the acquisition and plasticity of the neurotransmitter pheno-
type of different neuronal subpopulations remains a major
challenge in neurobiology. Choline acetyltransferase (ChAT)1
(EC 2.3.1.6) is the rate-limiting enzyme in the synthesis of
acetylcholine, one of the main neurotransmitters of the nervous
system. Cholinergic neurons in the central nervous system
include cells in the basal forebrain, cortex, motor nuclei, and
spinal cord. These neurons acquire their cholinergic phenotype
progressively as the expression of the ChAT gene increases
during development. In motor neurons of the spinal cord, the
levels of ChAT mRNA increase slowly during embryonic life
and more rapidly after birth, reaching maximal levels in the
adult (1). Developing neurons may switch from a non-cholin-
ergic to a cholinergic phenotype only after reaching the target
of innervation (2) and may also become cholinergic in response
to injury (3). In most of these circumstances, a major point of
control of the cholinergic phenotype has been demonstrated at
the transcriptional level (4, 5), suggesting the presence of reg-
ulatory elements in the ChAT gene controlling accurate time-
and cell-specific expression.
The ChAT gene comprises several exons including a number
of alternatively spliced 59-noncoding exons (6). Transcription of
the rat and mouse ChAT genes appears to initiate at multiple
promoters, resulting in the production of five different
59-mRNA sequences (6–9). Different upstream regions of the
ChAT gene have been shown to be necessary for cell type-
specific expression of reporter genes in cholinergic cell lines (6,
10–14). We have previously shown that a 3862-bp-long, but not
a 1520-bp-long, 59-flanking segment from the rat ChAT gene
promoter directs cell type-specific expression of a reporter gene
in cholinergic cells in vitro (10), suggesting that the intervening
2336-bp-long segment contains elements responsible for the
cell type-specific expression of the ChAT gene. In support of
this notion, we have recently demonstrated that this segment
from the ChAT gene promoter is able to confer cholinergic
specificity to a non-cholinergic promoter in an orientation-in-
dependent manner and to direct correct developmental and
tissue-specific expression to cholinergic cells in transgenic mice
(15). We now report the functional dissection of this region and
the identification of a neuron-restrictive silencer element and
cholinergic-specific enhancer sequences that cooperate to direct
cell type-specific expression in cholinergic neurons.
MATERIALS AND METHODS
Plasmid Construction and Site-directed Mutagenesis—A 2336-bp
EcoRI-HindIII fragment from a rat ChAT genomic lEMBL3 clone (10)
was isolated and subcloned into pBSKS1 (Stratagene, La Jolla, CA).
Nested deletions (Nested Deletion kit, Pharmacia, Uppsala) were made
from both 39- and 59-ends of the fragment and confirmed by DNA
sequence analysis. Heterologous promoter constructs were made by
subcloning fragments into the SalI site of pBLCAT2 (16). Deletion of the
ChAT NRSE was made by oligonucleotide site-directed mutagenesis as
described by Kunkel (17) using the oligonucleotide 59-TAAACACCG-
GCTCCTAGGAACTGGGGAGCCGCTCTACCTCCTGGC-39 and was
confirmed by DNA sequence analysis.
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RNA Preparation and RNase Protection Assay—Total RNA was pre-
pared from frozen tissue by the guanidine isothiocyanate/CsCl method
(18). Polyadenylated RNA was purified by chromatography on an oli-
go(dT)-cellulose column. Total RNA from cell lines was purified by the
method described by Chomczynski and Sacci (19). The recovery of RNA
was quantified spectrophotometrically. RNase protection assays were
performed using the RPAII Ribonuclease Protection Assay kit (Ambion
Inc., Austin, TX). The cRNA probes were a 450-bp PvuII-PstI fragment
from mouse NRSF, a 401-bp fragment spanning positions 640-1140 of
rat NRSF, and a 426-bp PvuII-PstI fragment from human NRSF (20)
cloned into pBSKS1. For determination of cell line mRNA levels, stand-
ard curves were made with spectrophotometrically quantified sense
cRNA produced from the same plasmids. Probes were labeled with
[a-32P]CTP by run-off transcription from the linearized plasmid. 2.5 3
105 cpm of probe and 10 mg of RNA were used in each hybridization. The
protected fragments were separated on a 5% denaturing polyacryl-
amide gel and subsequently exposed to x-ray film.
Cell Culture and Transfections—Fischer rat fibroblast (FR3T3),
mouse neuroblastoma (N2A), mouse basal forebrain cholinergic neuron
(SN6), mouse motor neuron (2F1.10.14, referred to here as MN1), and
human neuroblastoma (LAN5) cell lines were grown in Dulbecco’s mod-
ified Eagle’s medium with 10% fetal calf serum supplemented with 2
mM glutamine, 100 units/ml penicillin, and 100 mg/ml streptomycin (all
from Life Technologies, Inc.) at 37 °C in a 5% CO2 atmosphere. SN6 is
a cholinergic neuronal cell line derived from a fusion of mouse primary
septal neurons with the mouse neuroblastoma cell line N18TG2 (21).
MN1 is a cholinergic motor neuron cell line derived from a fusion of
N18TG2 with embryonic mouse spinal cord motor neurons (clone
2F1.10.14.7) (22). Cells grown to ;70% confluency were transfected
according to the calcium phosphate procedure. 35-mm wells were trans-
fected with 1.5 mg of DNA plus 0.5 mg of the reference plasmid pON260
(23) expressing b-galactosidase as an internal control for transfection
efficiency. For cotransfections, 1 mg of reporter plasmid and 4 mg of
NRSF-expressing pCMV-HZ4 (20) or parental vector pcDNA3 (Invitro-
gen) were used. Cells were harvested after 48 h in culture with phos-
phate-buffered saline containing 10 mM EDTA, transferred to 250 mM
Tris (pH 7.5), and lysed by five cycles of freeze-thawing. Samples were
equalized in protein content (24) and were incubated at 65 °C for 5 min
to destroy endogenous acetyltransferases and acetylases. CAT assays
were performed as described previously (25), and percentage conversion
was calculated after scintillation counting of TLC plates. The conver-
sion after a 2-h reaction from transfections of the construct with the tk
promoter alone was 5, 10, and 9% for the FR3T3, SN6, and LAN5 cell
lines, corresponding to 9, 17, and 15 nmol of converted acetyl-coenzyme
A, respectively.
Electrophoretic Mobility Shift Assay—Human NRSF was produced
by in vitro translation from the pREST-H1 plasmid (20) using the TNT
Coupled Reticulocyte Lysate system (Promega, Madison, WI). The prod-
uct was analyzed by SDS-polyacrylamide gel electrophoresis. Nuclear
extracts were made according to Andrews and Faller (26). Binding
reactions were performed in 20 ml of 20 mM HEPES (pH 7.6), 0.1%
Nonidet P-40, 10% glycerol, 1 mM dithiothreitol, 2.5 mM MgCl2, 250 mM
KCl, and 2 mg of poly(dI-dC)zpoly(dI-dC). 5 ml of in vitro translation
product or 10 mg of nuclear extract was preincubated in buffer on ice for
10 min; 1 3 104 cpm of probe and competitor were added; and the
reaction was incubated at room temperature for 20 min. For supershift
experiments, 1 ml of either polyclonal antiserum raised against the
zinc-finger region of mouse NRSF (20) or preimmune serum was then
added, and the reaction was incubated for another 30 min at room
temperature. The binding reaction was loaded onto a 6% nondenaturing
polyacrylamide gel and run in 0.25 3 Tris borate/ETDA buffer. The
ChAT NRSE oligonucleotide probe was labeled with [a-32P]dCTP by
Klenow fill-in. Oligonucleotides used were as follows: ChAT NRSE,
TAGGAACTGTCCAGCACCACGGACAGTTCCGGGAGCCGC; SCG10
NRSE, AGCTGCAAAGCCATTTCAGCACCACGGAGAGTGCCTCTGC;
and unrelated control, CCGTTGATATATCCCAATGGC.
RESULTS
Analysis of Regulatory Regions Directing Cell Type-specific
Expression of the ChAT Gene Promoter—We previously isolated
a distal region from the ChAT gene promoter containing a cell
type-specific silencer-like activity that restricts ChAT gene ex-
pression to cholinergic cells in vitro (10). This region encom-
passes 2336 bp of 59-flanking sequence and extends from an
EcoRI site at position 23859 to a HindIII site at position
21523. (The transcriptional start site, corresponding to posi-
tion 498 of the sequence published in Ref. 10, is herein defined
FIG. 1. 5*-Deletion analysis of the
upstream 2336-bp EcoRI-HindIII reg-
ulatory region of the rat ChAT gene
linked to a heterologous promoter.
Heterologous promoter constructs con-
taining the tk promoter were transiently
transfected into the mouse cholinergic
neuronal SN6, human non-cholinergic
neuronal LAN5, and rat FR3T3 fibroblast
cell lines. Cells were harvested after 48 h,
lysed, and subjected to CAT reporter gene
activity assay. A simplified map of the
corresponding region of the ChAT
genomic clone is shown. The 156-bp se-
quence containing the tk promoter is not
drawn to scale. Bars show mean 6 S.E. *,
p , 0.001 versus the tk construct (Stu-
dent’s t test).
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as 11.2) This region was recently shown to be able to direct
cholinergic-specific expression of a tk gene promoter in vitro
and in transgenic mice (15). To further characterize sequences
within this region controlling cell-type specificity, a series of
59-deletions were generated between positions 23859 (EcoRI)
and 21523 (HindIII) of the ChAT gene and subcloned up-
stream of a tk gene promoter linked to the bacterial CAT
reporter gene. The fragment of the tk promoter used allows
robust transcription in a variety of neuronal and non-neuronal
cell lines; a plasmid construct without promoter has no detect-
able activity. In the cholinergic neuronal SN6 cell line, this
analysis revealed a region with moderate enhancing activity
between positions 21523 and 22162 and another enhancer
upstream of position 23386 (Fig. 1). In agreement with our
previous results (15), the presence of the 2336-bp segment from
the ChAT gene (23859 construct) suppressed the activity of the
downstream tk promoter in the fibroblast cell line FR3T3 (Fig.
1). Progressive deletions from the 59-end of this region did not
show major differences in the transcriptional efficiency of pro-
moter constructs in FR3T3 cells (Fig. 1), indicating the pres-
ence of a silencing activity in the 39-end of this region. The
constructs were also analyzed in LAN5, a non-cholinergic hu-
man neuroblastoma cell line. In LAN5 cells, none of the 59-
deletion constructs showed a significant influence of the tk
promoter activity, with the exception of the 23386 construct,
which showed a reduction in activity similar to that seen in
SN6 cells (Fig. 1). Similar results were obtained in an equiva-
lent series of 59-deletions performed in a native ChAT gene2 P. Lo¨nnerberg and C. F. Iba´n˜ez, unpublished data.
FIG. 2. 5*-Deletion analysis of the upstream 2336-bp EcoRI-HindIII regulatory region of the rat ChAT gene. Homologous promoter
constructs were transiently transfected into the mouse cholinergic neuronal SN6 and rat 3T3 fibroblast cell lines. Cells were harvested after 48 h,
lysed, and subjected to CAT reporter gene activity assay. A simplified map of the corresponding region of the ChAT genomic clone is shown. Shaded
boxes, ChAT noncoding first exon sequence. Bars show mean 6 S.E. *, p , 0.05 versus the 21523 construct (Student’s t test).
FIG. 3. 3*-Deletion analysis of the
upstream 2336-bp EcoRI-HindIII reg-
ulatory region of the rat ChAT gene.
Heterologous promoter constructs con-
taining the tk promoter were transiently
transfected into the indicated cell lines.
Cells were harvested after 48 h, lysed,
and subjected to CAT reporter gene activ-
ity assay. A simplified map of the corre-
sponding region of the ChAT genomic
clone is shown. The 156-bp sequence con-
taining the tk promoter is not drawn to
scale. Bars show mean 6 S.E. *, p , 0.05;
**, p , 0.001 versus the tk construct (Stu-
dent’s t test).
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promoter construct (intact 59-region with its homologous pro-
moter) (Fig. 2).
Regulatory elements in the 2336-bp EcoRI-HindIII fragment
were further investigated in a series of 39-deletions. Deletions
upstream of position 22361 reduced the activity of the con-
struct in SN6 cells, consistent with the presence of a region
with enhancing activity in cholinergic cells (Fig. 3). In contrast,
these deletions progressively increased promoter activity in
FR3T3 cells (Fig. 3). Deletion of the most downstream 339 bp
resulted in a 3-fold increase in transcription in FR3T3 fibro-
blast cells (Fig. 3). A further 2-fold increase was obtained after
39-deletion of an additional 499 bp, indicating another region
with suppressing activity in FR3T3 cells. Promoter activity was
not substantially influenced by the 39-deletions in LAN5 cells,
with the exception of the 21862 construct, which suppressed tk
promoter activity (Fig. 3). Taken together, data from deletion
analyses indicated the presence of a silencing activity in non-
neuronal cells between positions 21862 and 21523 and several
upstream segments that cooperated to give enhancing activity
in cholinergic cells.
Localization of a NRSE in the ChAT Gene Promoter—4000
bp of the upstream region of the ChAT gene promoter were
sequenced and scanned for the presence of previously described
regulatory sequences (this sequence is available from the
EMBL Nucleotide Sequence Data Bank under accession num-
ber X92751). This search resulted in the identification of a
21-bp sequence (from positions 21580 to 21560) highly related
to the consensus sequence of the NRSE described previously in
other neuron-specific genes (Fig. 4) (27). This element has been
shown to repress expression in non-neuronal cells of several
neuronal genes including rat SCG10 (27), human synapsin I
(28), and rat type II sodium channel (29) genes, and it has also
been found in the promoter regions of several other neuron-
specific genes such as human dopamine b-hydroxylase (30) and
rat brain-derived neurotrophic factor (BDNF) (31). We there-
fore investigated the functional role of the ChAT NRSE-like
element in determining cell-type specificity in the ChAT gene
promoter. For this purpose, the 21-bp element was deleted by
site-directed mutagenesis in two heterologous ChAT gene pro-
moter constructs, i.e. positions 23859 to 21523 and positions
21799 to 21523, containing the tk promoter and the CAT
reporter gene. The activity of these constructs was compared
with that of the wild-type sequences and with the activity of the
tk promoter alone. The deletion did not affect the activity of the
23859 and 21799 constructs in cholinergic SN6 cells as as-
sessed by CAT activity (Fig. 5). In FR3T3 fibroblast cells,
deletion of the NRSE-like element increased promoter activity,
consistent with the role of the NRSE as a non-neuronal silencer
(Fig. 5). In the short construct (21799), the deletion restored
FIG. 4. Alignment of NRSE core sequences from different neu-
ron-specific genes. Shown are NRSEs from the ChAT, SCG10 (27),
type II sodium channel (NaII) (29), synapsin I (synI) (28), BDNF (31),
dopamine b-hydroxylase (DBH) (30), and Na,K-ATPase a3-subunit
(a3NKA) (33) genes.
FIG. 5. Role of the ChAT NRSE in determining cell-specific gene expression. The 21-bp sequence at position 21579 containing the ChAT
NRSE was deleted by site-directed mutagenesis in heterologous tk promoter constructs containing ChAT upstream regulatory sequences. After
transient transfection into the indicated cell lines, CAT reporter gene activity was assayed. A simplified map of the corresponding region of the
ChAT genomic clone is shown. X denotes the deleted NRSE. Solid boxes represent two tandem copies of a 39-bp oligonucleotide spanning the ChAT
NRSE. Bars show mean 6 S.E. (n 5 3). *, p , 0.005 versus the tk construct (Student’s t test).
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the level of CAT activity to that of the tk promoter alone (Fig.
5). Deletion of the ChAT NRSE had no major effect in LAN5
cells. Further evidence of the ability of the ChAT NRSE to
control neuron-specific gene expression was obtained by intro-
ducing a tandem NRSE oligonucleotide (23NRSE) upstream of
the tk promoter and the CAT reporter gene. Isolated from its
native sequence context, the tandem NRSE repressed the ac-
tivity of the tk promoter by ;3-fold in FR3T3 cells, but not in
SN6 or LAN5 cells (Fig. 5). Combined with the data from the
serial deletion analysis, these results suggest that the ChAT
NRSE contributes to the neuron-specific expression of the
ChAT gene promoter.
Binding of the Neuron-restrictive Silencing Factor to the
ChAT NRSE—A DNA-binding protein has been cloned on the
basis of its ability to bind to NRSEs in the SCG10 and type II
sodium channel genes (20, 32). We investigated whether this
protein, NRSF (also called REST), was able to interact with the
NRSE of the ChAT gene. Electrophoretic mobility shift assays
were performed with human NRSF in vitro translated from a
construct containing the zinc-finger DNA-binding domain (20)
and a 39-bp oligonucleotide probe containing the ChAT NRSE
and nine nucleotides each of 59- and 39-flanking sequence.
Human NRSF bound specifically to the ChAT NRSE in this
assay (Fig. 6A). Binding was prevented by excess nonradioac-
tive ChAT NRSE oligonucleotide or by an oligonucleotide con-
taining the NRSE from the SCG10 gene (Fig. 6A). An oligonu-
cleotide with a sequence unrelated to NRSEs did not compete
NRSF binding (Fig. 6A). However, binding was prevented by a
polyclonal antibody directed against a recombinantly produced
N-terminal fragment of NRSF containing the zinc-finger do-
main (20). These data show that NRSF is able to specifically
bind to the ChAT gene NRSE.
Next, we investigated whether FR3T3 cells contained NRSE
binding activity. Electrophoretic mobility shift assay performed
with FR3T3 nuclear extract revealed complexes of the expected
mobility (Fig. 6B). Binding was competed by an excess of un-
labeled oligonucleotide and by the polyclonal antiserum raised
against the zinc-finger domain of mouse NRSF (Fig. 6B). In
three independent experiments, anti-NRSF antibodies caused
a 60% reduction in binding compared with preimmune serum
(Fig. 6B). Because the anti-NRSF antiserum had been raised
against the N-terminal fragment of NRSF, the incomplete
inhibition might have been due to C-terminal regions in
native NRSF partially blocking access of the antibody. Com-
bined, these data demonstrate the presence of a NRSE bind-
ing activity in FR3T3 cells that is immunologically related to
NRSF.
Expression of NRSF mRNA in Different Cell Lines—These
results prompted us to investigate the endogenous expression
of NRSF in different cholinergic and non-cholinergic cell lines.
Ribonuclease protection assays (RPAs) were performed with
equal amounts of total RNA extracted from various cell lines
using riboprobes derived from the mouse and rat NRSF/REST
genes (20, 32). In addition to SN6 and FR3T3 cells, a mouse
cholinergic motor neuron hybrid cell line (MN1) (22) and a
mouse neuroblastoma cell line (N2A) were also analyzed and
compared (Fig. 7A). mRNA was quantitated against standard
curves made by RPA of various amounts of sense cRNA (data
not shown). NRSF mRNA levels in FR3T3 cells were ;30-fold
higher than in neuronal cell lines (Fig. 7B). Similarly, using a
FIG. 6. Binding of NRSF to the ChAT NRSE. A, an N-terminal
fragment of human NRSF containing the zinc-finger domains was pro-
duced by in vitro translation in a rabbit reticulocyte lysate. Electro-
phoretic mobility shift assays were performed with one-tenth of the in
vitro translation product (in vitro) and a 32P-labeled 39-bp oligonucleo-
tide spanning the rat ChAT NRSE as probe, with or without the addi-
tion of competitor oligonucleotides (comp) at a 500-fold molar excess.
Competitors used were the unlabeled probe oligonucleotide (control
(C)), the NRSE from the rat SCG10 gene (S), and an unrelated oligo-
nucleotide derived from the pBLCAT2 plasmid sequence (u). A poly-
clonal antiserum (a) raised against a recombinantly produced NRSF
fragment containing the zinc-finger domain was used to block binding of
NRSF to the probe. pre, preimmune serum. B, 10 mg of FR3T3 nuclear
protein extracts was used in electrophoretic mobility shift assay with
the ChAT NRSE oligonucleotide probe. Note that the unlabeled oligo-
nucleotide (comp) and anti-NRSF antibodies (a) compete binding to the
probe. Full-length human NRSF produced by in vitro translation in a
rabbit reticulocyte lysate was included for identification of the NRSF-
derived band (in vitro lane). The histogram shows the quantitation of
three independent experiments comparing preimmune and anti-NRSF
antisera. Optical density values with preimmune serum were arbi-
trarily set to 100. Bars show mean 6 S.E. *, p , 0.01 (one-group t test;
n 5 3).
FIG. 7. Analysis of NRSF mRNA expression in different cell
lines. A, 10 mg of total RNA from the indicated cell lines was used in a
RPA with cRNA probes derived from a 450-bp fragment of a mouse
NRSF cDNA or a 401-bp fragment of a rat NRSF cDNA. Yeast tRNA
was used as a negative control. B, shown is the quantitation of the RPA
analysis of NRSF mRNA. Bars show picograms of mRNA/10 mg of total
RNA and represent mean 6 S.E. (n 5 2).
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human NRSF riboprobe, low levels of NRSF mRNA were de-
tected in LAN5 cells, but 10-fold higher levels were seen in the
non-neuronal cell line HeLa (data not shown). In agreement
with these data, low levels of NRSE binding activity were found
in nuclear extracts of SN6 cells (data not shown).
Silencing Activities of Overexpressed NRSF in Cholinergic
Cells—Previous studies have indicated that NRSF may act in a
concentration-dependent manner, suggesting that low levels of
NRSF may be insufficient for silencing activity (20, 32). To test
this hypothesis and to get direct evidence of the role of NRSF in
determining neuron-specific expression of the ChAT gene, we
assayed different heterologous promoter constructs containing
the ChAT NRSE after overexpression of human NRSF in
FR3T3 and SN6 cells. In the first experiment, we used a con-
struct containing two tandem ChAT NRSEs in front of the tk
promoter. As expected, overexpression of NRSF in FR3T3 cells
did not affect expression from this construct (Fig. 8A), consist-
ent with the high levels of endogenous expression of NRSF
already present in these cells. In contrast, overexpression of
NRSF in SN6 cells repressed the activity of this promoter
construct by 7-fold (Fig. 8A). NRSF overexpression had, how-
ever, no effect on the activity of the tk promoter alone (Fig. 8A),
suggesting that direct binding of NRSF to the ChAT NRSE is
required for repression of transcription. RPA of equal amounts
of RNA from transfected cells demonstrated that the lack of
effect of overexpressed NRSF in FR3T3 cells was not due to
poor overexpression (Fig. 8B).
In the second experiment, we tested the effects of NRSF
overexpression on the activity of heterologous promoter con-
structs containing two different segments of the 2336-bp regu-
latory region of the ChAT gene in SN6 cells. Constructs in
which the 21-bp NRSE sequence had been deleted were also
included for comparison. Overexpression of NRSF caused a
statistically significant 3-fold reduction in the activity of the
21799 construct, containing 276 bp from the proximal part of
the 2336-bp ChAT gene fragment including the NRSE (Fig. 9).
More important, deletion of the NRSE in this sequence abol-
ished the effects of NRSF overexpression (Fig. 9), confirming
that NRSF activity requires an intact NRSE. Interestingly,
NRSF overexpression had no effect on the activity of the
23859 construct, regardless of the presence or absence of the
NRSE (Fig. 8), suggesting an interaction between upstream
sequences in the ChAT gene promoter and the NRSE in cho-
linergic cells.
DISCUSSION
In this study, we report on the identification and functional
analysis of positive and negative regulatory elements in a 2336-
bp-long upstream region of the rat ChAT gene promoter capa-
ble of directing cell type-specific gene expression. We have
previously demonstrated that this 2336-bp-long DNA sequence
allows correct temporal and spatial expression of a reporter
gene when linked to a heterologous tk promoter in transgenic
mice (15). In vitro, this DNA fragment enhances the activity of
a tk promoter in the cholinergic neuronal SN6 cell line, but
suppresses expression from this promoter in the fibroblast cell
line FR3T3 (15). Using deletion analysis, we have now localized
the majority of the silencer activity of this fragment to its most
39-region, where a 21-bp-long sequence highly related to a
silencer element present in several other neuron-specific genes
was found. This element, termed NRSE or RE1, has been found
FIG. 8. Effect of NRSF overexpression on the activity of a
ChAT NRSE-linked tk promoter. Reporter gene constructs were
made containing either a tk promoter alone (tk) or two tandem copies of
the rat ChAT NRSE in the sense orientation in front of the tk promoter
(23NRSE) in front of the chloramphenicol acetyltransferase reporter
gene. The expression plasmid pCMV-HZ4, producing human NRSF (1),
or a control plasmid (2) was transfected at a 4-fold molar excess with
respect to reporter constructs, and 2 days after transfection, cell lysates
were analyzed. A, reporter gene activity assays. The mean activity of
the tk promoter alone was arbitrarily set to 1. Bars show mean 6 S.E.
(n 5 3). *, p , 0.025 (Student’s t test). B, ribonuclease protection assay
analysis of human NRSF mRNA expression in cell lines cotransfected
with pCMV-HZ4 and the 23NRSE construct. 10 mg of total RNA was
analyzed in each reaction. Yeast transfer RNA (ytRNA) was used as a
negative control. Note that the human NRSF riboprobe does not detect
endogenous NRSF mRNA in these cell lines.
FIG. 9. Effects of NRSF overexpression on the activity of reg-
ulatory sequences from the ChAT gene in SN6 cells. CAT reporter
gene plasmids containing the complete 2336-bp regulatory fragment
from the ChAT gene (23859 1 tk) or only the most proximal 276 bp
from this fragment (21799 1 tk) in front of a tk promoter were tran-
siently cotransfected with a 4-fold molar excess of either a human
NRSF expression plasmid (hatched bars) or a control plasmid (open
bars). For comparison, constructs with a deletion in the ChAT NRSE
(23859D 1 tk and 21799D 1 tk, respectively) were also included. 48 h
after transfection, cells were harvested, and CAT reporter gene activity
in cell lysates was measured. The activity of the tk promoter alone was
arbitrarily set to 1. Bars show mean 6 S.E. (n 5 3). *, p , 0.05
(Student’s t test).
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to suppress non-neuronal expression of SCG10 (27), type II
sodium channel (29), synapsin I (28), dopamine b-hydroxylase
(30), and Na,K-ATPase a3-subunit (33) genes. The ChAT NRSE
differs from the NRSE consensus sequence (33) in two nucleo-
tides located in positions known to vary among other NRSE
sequences (Fig. 4). Interestingly, like all NRSE-containing pro-
moters characterized so far, the ChAT gene promoter studied
here lacks a TATA box (11).2
A nuclear protein that binds to the NRSE has recently been
cloned (20, 32). This protein, termed NRSF or REST, contains
eight zinc fingers and has been shown to bind the NRSEs of the
SCG10, synapsin I, type II sodium channel, and BDNF genes
(20, 32). We have shown here that NRSF is able to bind to the
NRSE of the ChAT gene and to modulate gene promoter activ-
ity through this element. NRSF mRNA was found to be ex-
pressed in all three cell lines used for transfection studies,
although the levels of NRSF mRNA in non-neuronal FR3T3
cells were substantially higher than in SN6 cells. Two other
cholinergic lines of neuronal origin, MN1 and N2A, also ex-
pressed low levels of NRSF mRNA. In vivo, NRSF mRNA has
been found in some subpopulations of embryonic neural crest-
derived peripheral neurons (20, 32). Thus, although NRSF has
been postulated to act as a repressor of gene expression in
non-neuronal cells, it can also be found to some extent in
neuronal cells. Furthermore, the presence of a NRSE-like ele-
ment in the promoter of the BDNF gene, which is also ex-
pressed outside the nervous system, suggests that the mecha-
nism whereby NRSF regulates gene expression may be more
complex than previously anticipated. Thus, for example, it is
conceivable that NRSF expression in embryonic neurons could
reflect a role of NRSF in suppressing more mature neuronal
phenotypes that should not be manifested until later stages of
neuronal development. On the other hand, previous studies
have indicated that NRSF may act in a concentration-depend-
ent manner and that a threshold level of NRSF may be re-
quired for efficient repression of transcription (20, 32). Thus,
the levels of NRSF found in some cells of neuronal origin may
not be sufficient for transcriptional repression. In support of
this hypothesis, we have found that overexpression of NRSF in
SN6 cells did suppress expression from a NRSE-linked pro-
moter, suggesting that endogenous levels of NRSF in these
cells may be below the threshold required for silencer activity.
The expression of NRSF in cells of neuronal origin could also
reflect alternative roles for NRSF in these cells and suggests
that neurons may express additional factors that either cancel
or modify the effects of NRSF. Evidence for the existence of
such a mechanism was obtained from the analysis of upstream
sequences in the ChAT gene promoter.
An enhancing activity specific for cholinergic cells was also
found in the 2336-bp upstream region of the ChAT gene. Dele-
tion analysis of this region revealed several segments that
cooperated to achieve this enhancing activity. In particular, the
distal 500-bp segment of this region, in combination with down-
stream sequences situated around 22500 bp, but not alone,
was able to stimulate transcription in cholinergic cells. These
upstream sequences conferred additional specificity to the ac-
tivity of a NRSE-linked promoter, suggesting that they coop-
erate with the ChAT NRSE in directing expression to cholin-
ergic neurons. From experiments with transformed Drosophila
melanogaster flies, the Drosophila ChAT gene expression
seems to be controlled through a similar interaction between
negative and positive elements residing in 7.4-kilobase pair
upstream sequence (13, 14). In the dopamine b-hydroxylase
gene, a cooperation between the NRSE and a cAMP-responsive
element appears to be required for tissue-specific expression
(30). The fact that the enhancing effect of the upstream region
of the ChAT gene appeared to be confined to SN6 cells suggests
that it contains elements that may function as enhancers in
specific subpopulations of neurons. Further evidence for an
interaction between upstream and downstream regulatory el-
ements in the ChAT gene promoter was obtained after overex-
pression of NRSF in cholinergic SN6 cells. The fact that excess
NRSF did not affect the activity of a construct that included the
upstream enhancing sequences from the ChAT gene promoter
indicates that additional elements in this region may be able to
recruit factors that prevent NRSF-mediated silencing. These
factors may interact directly with the NRSFzNRSE complex
or may simply prevent binding of NRSF to its cognate ele-
ment. On the other hand, the absence of such interactions in
non-cholinergic cells would allow NRSF suppressing activi-
ties to be fully manifested. Thus, NRSF appears to be just one
component of the mechanism regulating neuron-specific gene
expression, which seems to also depend upon the expression
status of additional regulatory factors. The mammalian tran-
scriptional regulator NF-kB has been shown to function ei-
ther as a repressor or as an activator depending on the
actions of the high mobility group-like proteins DSP1 and
HMGI(Y) (34). Could NRSF act as a dual repressor/activator
depending on the cell context? Our 39-deletion analysis sug-
gests that the ChAT NRSE is not required for the enhancing
effects of upstream regulatory sequences of the ChAT gene,
although it does not rule out that such a mechanism may be
operating in vivo.
Taken together, our data reveal a modular arrangement of
regulatory elements in the ChAT gene promoter that together
determine the cell-type specificity of ChAT gene expression. At
least two kinds of elements were found to cooperate to direct
specific gene expression to cholinergic neurons, namely a neu-
ron-restrictive silencer element and cholinergic-specific en-
hancer sequences. Our results suggest that similar arrange-
ments of neuron-restrictive silencers and specific enhancers
may be found in the promoter regions of other neuron-specific
genes; this may constitute a general mechanism for the control
of gene expression within specific subsets of neurons.
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